Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Greenwich Lifesciences Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GLSI
Nasdaq
2836
https://greenwichlifesciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Greenwich Lifesciences Inc
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
- Mar 13th, 2024 10:00 am
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
- Mar 12th, 2024 10:00 am
Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares
- Mar 7th, 2024 2:00 pm
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
- Feb 27th, 2024 11:00 am
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
- Feb 22nd, 2024 11:00 am
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
- Feb 14th, 2024 11:00 am
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate
- Jan 22nd, 2024 12:45 pm
Insiders hold 54% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), and they've been buying recently
- Dec 11th, 2023 11:52 am
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
- Nov 21st, 2023 11:00 am
Greenwich LifeSciences Insiders Added US$653.7k Of Stock To Their Holdings
- Nov 14th, 2023 10:45 am
Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc
- Sep 13th, 2023 9:02 pm
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth
- Aug 15th, 2023 11:50 am
Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company
- Apr 6th, 2023 2:37 pm
Scroll